Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/1998
03/17/1998US5728752 Lactone polymers
03/17/1998US5728738 Mixing alkali with sodium mercaptoethylsulfonate
03/17/1998US5728681 Infusion preparation and two compartment container containing the preparation
03/17/1998US5728680 Methods for normalizing numbers of lymphocytes
03/17/1998US5728553 High purity albumin and method of producing
03/17/1998US5728521 Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
03/17/1998US5728405 Method for preventing keratocyte loss
03/17/1998US5728403 Coating technology for taste masking orally administered bitter drugs
03/17/1998US5728402 Controlled release formulation of captopril or a prodrug of captopril
03/17/1998US5728401 Effervescent ranitidine formulations
03/17/1998US5728400 Apparatus and process for strengthening low density compression dosage units and product therefrom
03/17/1998US5728396 Sustained delivery of leuprolide using an implantable system
03/17/1998US5728395 Hydroxylapatite base porous beads filler for organism and method of producing the same
03/17/1998US5728392 Cosmetic and/or dermatological composition for the treatment of aging, containing ceramides, and the use thereof
03/17/1998US5728088 Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
03/17/1998CA2185600A1 Water-soluble concentrates containing cyclosporins
03/12/1998WO1998010281A1 Use of a liquid crystalline phase for determining the distribution of a chemical substance between a hydrophobic and a hydrophilic environment
03/12/1998WO1998009985A2 Anti-inflammatory peptides and uses thereof
03/12/1998WO1998009721A2 Emulsifier mixtures and their use for preparing pit emulsions
03/12/1998WO1998009668A2 Use of amphiphiles as phosphatidyl choline synthesis inhibitors
03/12/1998WO1998009665A2 Iontophoretic method of using phenylephrine to improve the effect of local anesthetics
03/12/1998WO1998009654A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta
03/12/1998WO1998009650A1 Vaccinal preparations
03/12/1998WO1998009645A1 Peptide-containing drug compositions for oral administration
03/12/1998WO1998009633A2 Pharmaceutical compositions
03/12/1998WO1998009631A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
03/12/1998WO1998009624A1 Water-soluble vitamin composition that provides excellent tablets and process for producing the same
03/12/1998WO1998009617A1 Product with extender effect
03/12/1998WO1998009616A1 Solid foamed active substance preparations
03/12/1998WO1998009615A1 Herbal composition for treating prostate carcinoma
03/12/1998WO1998009614A1 Hydrogel base permeable device containing live cells, and its applications
03/12/1998WO1998009613A1 Process to manufacture implants containing bioactive peptides
03/12/1998WO1998009597A2 Cushioning beads and tablet comprising the same capable of forming a suspension
03/12/1998WO1998009591A1 Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
03/12/1998WO1998009520A1 Antimicrobial compositions
03/12/1998WO1998002169A3 Novel formulations for the administration of fluoxetine
03/12/1998WO1998002147A3 Transdermal therapeutic systems
03/12/1998WO1998002146A3 Chemo-mechanical expansion delivery system
03/12/1998WO1998001161A3 Gene therapy delivery system for targeting to endothelia
03/12/1998WO1997046262A3 Membrane incorporation of texaphyrins
03/12/1998WO1997041895A3 TREATMENT OF ASTHMA WITH TNFR-Ig
03/12/1998DE19636364A1 Medicament for neutralising blood or other body fluids
03/12/1998CA2264286A1 Antimicrobial compositions
03/12/1998CA2264285A1 Anti-inflammatory peptides and uses thereof
03/12/1998CA2262693A1 Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
03/12/1998CA2261655A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
03/12/1998CA2236595A1 Process to manufacture implants containing bioactive peptides
03/11/1998EP0828005A2 Apoptotic agents for tumor cells of the nervous system
03/11/1998EP0827749A2 Peritoneal dialysis solution
03/11/1998EP0827748A2 Peritoneal dialysis solution
03/11/1998EP0827743A1 Use of histone decarboxylase inhibitors for treating fibrosis
03/11/1998EP0827742A1 Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
03/11/1998EP0827741A2 Composition for transdermal delivery system containing nonsteroidal anti-inflammatory drug as an active ingredient
03/11/1998EP0827513A1 Methods of treatment and diagnostic visualisation, particularly in cancer
03/11/1998EP0827511A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
03/11/1998EP0827412A1 Peptide radiopharmaceutical applications
03/11/1998EP0827402A2 Compositions containing fatty acids for improving digestion and absorption in the small intestine
03/11/1998EP0827399A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
03/11/1998EP0827398A1 Pharmaceutical dosage form for colonic delivery
03/11/1998EP0827397A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
03/11/1998EP0827396A1 Production scale method of forming microparticles
03/11/1998EP0827395A1 Topically applicable agents for treating and preventing alopecia
03/11/1998EP0827394A1 Sterilisable paste product for topical application
03/11/1998EP0827393A1 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament
03/11/1998EP0788351A4 Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
03/11/1998EP0677126B1 Antiviral topical pharmaceutical compositions
03/11/1998EP0660717B1 Aminosteroids for ophthalmic use
03/11/1998EP0659081B1 Dexpanthenol-containing plaster for the transdermal application of steroid hormones
03/11/1998CN1175904A Use of inorganic aerogels in pharmacy
03/11/1998CN1175903A Method of treating adenosine depletion
03/11/1998CN1175901A Banded prologed release active agent dosage form
03/11/1998CN1175898A Method for preparing preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders
03/11/1998CN1175886A Use of aerogels in agriculture
03/11/1998CN1175462A Anti-inflammatory and analgesic plaster for trauma and preparing method thereof
03/11/1998CN1175432A Gingko seed and ginseng capsule
03/11/1998CN1175428A Medical ointment for hyperosteogeny
03/11/1998CN1175427A Traditional Chinese medicine spray and ointment gauze for treatment of wound
03/11/1998CN1175422A Ant and pollen capsule
03/11/1998CN1175419A Lotion for treatment of piles
03/11/1998CN1175412A Toothache preparation
03/11/1998CN1175409A Anti-inflammatory analgesic adhesive plaster and preparing method thereof
03/11/1998CN1175408A Double coptis root spray and nasal liniment and preparing process thereof
03/11/1998CN1175407A Clear hydroalcoholic multivitamin solution containing physiologically effective amounts of beta-carotene
03/11/1998CN1175378A Cold tea particle contg. 24 components and producing method thereof
03/10/1998US5726212 Polymer membrane having a high permeability for alkanol
03/10/1998US5726209 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
03/10/1998US5726201 Bis-(2-ethylhexyl)-sodium-sulfosuccinate surfactant; storage stability; uniform dissolution
03/10/1998US5726181 Formulations and compositions of poorly water soluble camptothecin derivatives
03/10/1998US5726180 Caffeine, dextromethorphan, phenylpropanolamine, ibuprofen
03/10/1998US5726164 Nanosuspensions for intravenous administration
03/10/1998US5726161 Bound starch particles with voids containing functional substances, i.e., insecticides, herbicides, vitamins, bacteriostats and drugs for sustained release; drug delivery
03/10/1998US5726160 Treatment of diseases such as cystic fibrosis, emphysema, bronchitis and sinusitis
03/10/1998US5725887 Hydrogen peroxide source
03/10/1998US5725886 Microcrystalline cellulose spheronization composition
03/10/1998US5725884 Cellulose excipients, slurrying with silicon dioxide, agglomeration and drying
03/10/1998US5725883 Microcrystalline cellulose
03/10/1998US5725881 Biocompatible, bioabsorbable material suitable for implantation
03/10/1998US5725880 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
03/10/1998US5725879 Veterinary tablet intended especially for cats
03/10/1998US5725878 Pharmaceutical composition comprising HIV protease inhibiting compounds
1 ... 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 ... 2991